Clinical Trials on Tyrosine Kinase Inhibitor

Total 8 results

  • NCT04862780
    Recruiting
    Conditions: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Respiratory Tract Neoplasms, Neoplasms, Neoplasms by Site, Lung Diseases, Respiratory Tract Disease, Carcinoma, Bronchogenic, Bronchial Neoplasms, Adenocarcinoma, Carcinoma, Neoplasms by Histologic Type, Neoplasms, Nerve Tissue, EGFR T790M, EGFR C797S, EGFR L858R, EGFR Gene Mutation, EGF-R Positive Non-Small Cell Lung Cancer, EGFR Exon 19 Deletion, EGFR Mutation Resulting in Tyrosine Kinase Inhibitor Resistance, EGFR Activating Mutation, Protein Kinase Inhibitors, Antineoplastic Agents, Thoracic Neoplasms
  • NCT04807166
    Not yet recruiting
    Conditions: Ovarian Neoplasms, Fallopian Tube Neoplasms, Neoplasms by Site, Genital Neoplasms, Female, Neoplasms, Glandular and Epithelial, Neoplasms by Histologic Type, Carcinoma, Ovarian Epithelial, Ovarian Diseases, Genital Diseases, Female, Endocrine System Diseases, Carcinoma, Anlotinib, Angiogenesis, Antineoplastic Agents, Tyrosine Kinase Inhibitor
  • NCT03996096
    Recruiting
    Conditions: Chronic Myeloid Leukemia, Tyrosine Kinase Inhibitor, Withdrawal Syndrome
  • NCT01914484
    Completed
    Conditions: Chronic Phase Chronic Myeloid Leukemia, Accelerated Phase Chronic Myeloid Leukemia, Blastic Phase Chronic Myeloid Leukemia, Philadelphia Positive Acute Lymphoblastic Leukemia, Resistant to Tyrosine Kinase Inhibitor Therapy
  • NCT03952312
    Recruiting
    Conditions: Cancer, Cancer, Treatment-Related, Medication Adherence, Communication, Tyrosine Kinase Inhibitor
  • NCT04493827
    Completed
    Conditions: Adenocarcinoma of Lung Stage IV, Adenocarcinoma of Lung, Response to Tyrosine Kinase Inhibitor in, Somatic
  • NCT03624530
    Recruiting
    Conditions: Philadelphia Chromosome Positive Acute Lymphocytic Leukemia, Tyrosine Kinase Inhibitor, Minimal Residual Disease, Allogeneic Hematopoietic Stem Cell Transplantation
  • NCT02738983
    Unknown status
    Conditions: Non-small Cell Lung Cancer, Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI)